IL6 and neoplasm: Altogether, this suggests how the synergistic effect of gut-modulated pro-inflammatory cytokines, IL-6/17, in upregulating NLRP3 and associated signaling mechanisms, all of which culminate to progress tumor development at later stages (Figure 3).